Loading clinical trials...
Loading clinical trials...
A Prospective, Phase II Trial of a Trimodality Regimen for Stage III (N2) Non-small-cell Lung Cancer Using Concurrent Chemoradiotherapy as Induction Treatment Followed by Subsequent Resection
Conditions
Interventions
Neoadjuvant Chemoradiotherapy
Locations
1
China
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Start Date
March 1, 2013
Primary Completion Date
June 1, 2015
Completion Date
June 1, 2016
Last Updated
August 21, 2013
Lead Sponsor
Zhejiang Cancer Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions